PROS1 and COVID-19: In this work, aiming to develop a scalable bioprocess to produce high-quality S protein for inclusion in a virosome-based COVID-19 vaccine candidate, different signal peptides, baculovirus transfer vectors, cell lines, infection strategies and formulation buffers were explored.